Brind.

James C. Foster leads Charles River Laboratories during a period of stabilization regarding biopharma demand.

2 reports, 1 independent Updated Aug 5

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

James C. Foster leads Charles River Laboratories during a period of stabilization regarding biopharma demand.

Who's involved

What this event is mainly about

James C. Foster Charles River Laboratories

Keep exploring

The entities involved

James C. Foster
American businessman

Nothing else this week.
Charles River Laboratories
major US biomedical company
- Agilent Technologies and Charles River Laboratories are both companies operating in the life sciences sector.Sat 11:57
- Apollo is the digital client engagement platform for Charles River Laboratories, and Mark Mintz serves as CIO and head of global shared services.Sat 11:57

Coverage

Newest first; wire copies grouped

Aug 6StockStoryCharles River Laboratories (NYSE:CRL) Delivers Impressive Q2 Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue expectations , but sal

1 more outlet ran the same wire story

Aug 5financialcontent.com